NO20014478L - Behandling av visse kreftformer forbundet med vektökning - Google Patents

Behandling av visse kreftformer forbundet med vektökning

Info

Publication number
NO20014478L
NO20014478L NO20014478A NO20014478A NO20014478L NO 20014478 L NO20014478 L NO 20014478L NO 20014478 A NO20014478 A NO 20014478A NO 20014478 A NO20014478 A NO 20014478A NO 20014478 L NO20014478 L NO 20014478L
Authority
NO
Norway
Prior art keywords
treatment
weight gain
certain cancers
cancers associated
certain
Prior art date
Application number
NO20014478A
Other languages
English (en)
Other versions
NO20014478D0 (no
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20014478D0 publication Critical patent/NO20014478D0/no
Publication of NO20014478L publication Critical patent/NO20014478L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014478A 1999-03-19 2001-09-14 Behandling av visse kreftformer forbundet med vektökning NO20014478L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12525099P 1999-03-19 1999-03-19
PCT/US2000/007361 WO2000056323A1 (en) 1999-03-19 2000-03-17 Treatment of certain cancers associated with weight gain

Publications (2)

Publication Number Publication Date
NO20014478D0 NO20014478D0 (no) 2001-09-14
NO20014478L true NO20014478L (no) 2001-10-29

Family

ID=22418838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014478A NO20014478L (no) 1999-03-19 2001-09-14 Behandling av visse kreftformer forbundet med vektökning

Country Status (19)

Country Link
EP (1) EP1171106A1 (no)
JP (1) JP2002539255A (no)
KR (1) KR20010113765A (no)
CN (1) CN1399545A (no)
AU (1) AU3632000A (no)
BG (1) BG105998A (no)
BR (1) BR0009161A (no)
CA (1) CA2367045A1 (no)
CZ (1) CZ20013281A3 (no)
HU (1) HUP0200497A2 (no)
IL (1) IL145239A0 (no)
MX (1) MXPA01009470A (no)
NO (1) NO20014478L (no)
NZ (1) NZ514012A (no)
PL (1) PL351958A1 (no)
SK (1) SK13372001A3 (no)
TR (1) TR200102692T2 (no)
WO (1) WO2000056323A1 (no)
ZA (1) ZA200107687B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622600A1 (en) * 2003-04-28 2006-02-08 Cipla Ltd. Pharmaceutical formulation comprising anti-obesity agent and acidulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
PL351958A1 (en) 2003-07-14
AU3632000A (en) 2000-10-09
CA2367045A1 (en) 2000-09-28
CZ20013281A3 (cs) 2002-07-17
IL145239A0 (en) 2002-06-30
BG105998A (en) 2002-06-28
CN1399545A (zh) 2003-02-26
NZ514012A (en) 2001-09-28
SK13372001A3 (sk) 2002-07-02
TR200102692T2 (tr) 2002-03-21
BR0009161A (pt) 2002-01-22
NO20014478D0 (no) 2001-09-14
EP1171106A1 (en) 2002-01-16
WO2000056323A1 (en) 2000-09-28
ZA200107687B (en) 2002-12-18
HUP0200497A2 (en) 2002-08-28
JP2002539255A (ja) 2002-11-19
MXPA01009470A (es) 2004-03-19
KR20010113765A (ko) 2001-12-28

Similar Documents

Publication Publication Date Title
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
EP1154782A4 (en) TAXAN DERIVATIVES FOR TARGETED CANCER THERAPY
PL352993A1 (en) Methods of treating and/or suppressing weight gain
IL157425A0 (en) Treatment of solid tumours with paramycin derivatives
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE60009147D1 (de) Admantan derivate
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE60013127D1 (de) 5-phenyl-pyrimidine derivate
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
NO20015738L (no) Terapeutisk bruk av melatonin
ATE317389T1 (de) 4-phenyl-pyrimidine derivate
NO20014725D0 (no) Forbedret kreftbehandling med temozolomid
NO20014478D0 (no) Behandling av visse kreftformer forbundet med vektökning
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO20013795D0 (no) Regulering av anestesi
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20022446L (no) Etere av O-desmetyl-venlafaxine
NO993313L (no) Derivater av 5-nitrofurfural
GB9911183D0 (en) Treatment of cancers
NO20014476D0 (no) Behandling av hiatial hernia
FI991138A0 (fi) Normobarisen hypoksian käyttö terapeuttisesti
GB9911346D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers